Related Experiment Videos
Extracorporeal membrane oxygenation for severe respiratory failure
Scott K Alpard1, Joseph B Zwischenberger
1Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
Chest Surgery Clinics of North America
|July 19, 2002
Summary
Extracorporeal membrane oxygenation (ECMO) provides gas exchange to support failing lungs, offering a vital alternative to mechanical ventilation. This technology has demonstrated significant survival benefits in neonates with respiratory failure.
Area of Science:
- Critical Care Medicine
- Cardiopulmonary Support
- Pediatric Respiratory Medicine
Background:
- Mechanical ventilation can cause lung injury (barotrauma/volutrauma).
- Extracorporeal technology offers "lung rest" to facilitate healing.
- Extracorporeal membrane oxygenation (ECMO) is a modified cardiopulmonary bypass for gas exchange.
Purpose of the Study:
- To evaluate the efficacy of ECMO in managing respiratory failure.
- To assess ECMO's impact on mortality rates in various age groups.
Main Methods:
- Utilizing extracorporeal membrane oxygenation (ECMO) for gas exchange.
- Applying ECMO as a form of mechanical circulatory support.
Main Results:
- ECMO decreases mortality in neonatal, pediatric, and adult respiratory failure.
- In neonates, 20,638 patients treated with ECMO showed a 77% survival rate.
- This survival rate is significant given the estimated 78% mortality without ECMO.
Conclusions:
- ECMO is an effective life-saving therapy for severe respiratory failure across age groups.
- The technology facilitates lung rest and avoids ventilator-induced lung injury.
- ECMO offers a high survival rate in critically ill neonates.